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of Malignant Minor Salivary Gland Tumors
Kamran Bokhari
ABSTRACT
Minor salivary gland tumors account for 2 to 4% of all head and
neck cancers. These tumors are classically slow growing with
patients being aware of their presence over months or even
years. They are usually innocuous, asymptomatic and do not
interfere with function till they attain large size.
This retrospective study of malignant minor salivary gland
tumors seen at Regional Cancer Center, Thiruvananthapuram,
India over a period of 24 years included 84 cases.
Aims: To assess the history, clinical presentation, pathological
types of cases involving malignant minor salivary gland tumors
and their influence on survival.
Methods: The study was carried out in the division of surgical
oncology, Regional Cancer Center, Thiruvananthapuram, India.
A retrospective study design was adopted to assess the history,
clinical presentation, pathological types. The cases were
extracted from the electronic database by using International
Classification of Diseases of Oncology (ICD-O) (Ist edition)
codes of histology and sites. All patients were restaged using
American Joint Committee on Cancer (AJCC) Tumor, Node
and Metastasis (TNM) classification (2002). Demographic
factors, clinical, histopathological findings were displayed with
frequency tables. Survival was estimated by Kaplan-Meier
method (Kaplan EL, Meier P: Nonparametric estimation from
incomplete observations. J Amer Statist Assn 1958;53:457-81).
Results: Mucoepidermoid carcinoma was the most common
histopathological variant followed by adenoid cystic carcinoma.
Mean age of the patients was 46.7 years. The overall disease
free survival observed at 2 and 5 years in the present study
was 73.3 and 59.7% respectively.
Conclusion: The histological type of minor salivary gland tumor
was found to significantly influence survival. Gender and habits
had no significant influence on survival.
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INTRODUCTION
As many as 80% of minor salivary gland tumors are
malignant. Histological differentiation and classification,
clinical presentation, gender predilections and topographical
site are the factors that mainly influence the efficacy of
different therapy’s. The minor salivary gland tissues begin
their embryologic development as solid buds from the oral
epithelium. As the epithelial buds proliferate, solid cords
appear and develop into double layer of cuboidal progenitor
cells under the influence of surrounding mesenchymal tissue.
Progenitor cells differentiate into various ducts, acini and
myoepithelia.
Tumors arising in the minor salivary glands are rare.1 In
terms of salivary gland malignancy, it is a generally accepted
norm that the smaller the gland in which the tumor arises,
the greater the likelihood of its being malignant.2 There is a
remarkable variation in clinical presentation, behavior and
histology of these neoplasms.3 The malignant salivary gland
tumors deviate from the other malignant tumors being
classically slow growing, with patients being aware of its
presence late. They are usually innocuous, asymptomatic
and do not interfere with function. Ulceration, a classical
diagnostic feature only seen secondarily from either
masticatory or denture trauma or pressure.4 Although both
major and minor salivary gland shares the same histogenesis
and function, there are distinct differences in their neoplastic
patterns. Adenoid cystic carcinoma is the most common
malignancy in the minor salivary gland and mucoepidermoid
carcinoma has the highest propensity for lymphatic
metastasis.4
The percentage of malignant or potentially malignant
tumors in minor salivary glands is much higher than in major
glands. Adenoid cystic carcinoma is the most prevalent
histological type and palate the most common site.5 Tumor
size, histology and site are the most important prognostic
factors in malignant minor salivary gland tumors. Resection
with good margin is adequate treatment for small lesions
and large, poorly differentiated tumors require a combined
approach (surgery and radiation therapy).6 Early diagnosis
and treatment of minor salivary gland carcinoma likely leads
to have a better outcome.7
This paper aims to assess the history, clinical
presentation, pathological types of cases involving malignant
minor salivary gland tumors and their influence on survival.
METHODS
The study was carried out in the division of surgical





India. A retrospective study design was adopted to assess
the history, clinical presentation, pathological types. Eighty-
four cases of malignant minor salivary gland tumors of the
upper aerodigestive tract, viz. palate, buccal mucosa, tongue,
nasopharynx and oropharynx treated between 1982 and 2005
were included in the study. All the tumors were malignant,
had histological confirmations and were exclusively
confined to minor salivary glands.
The cases were extracted from the electronic database
by using International Classification of Diseases of
Oncology (ICD-O) (Ist edition) codes of histology and sites.
All patients were restaged using American Joint Committee
on Cancer (AJCC) tumor, node and metastasis (TNM)
classification (2002).
Demographic factors, clinical, histopathological findings
were displayed with frequency tables. Survival was
estimated by Kaplan-Meier method.
RESULTS
This retrospective study on malignant minor salivary gland
tumors between the period 1982 and 2005 included 84 cases.
Mean age of the patients was 46.7 years (range 8-76 years).
Table 1 shows the gender distribution in the present
study. There were nearly equal number of patients in both
the genders. No gender predilection was observed.
Of the 84 patients, 22 (26.2%) patients had no habits,
while only eight (9.5%) had current habits and one had past
habits (Table 2). History of habits included either smoking,
alcoholism, pan chewing. Gutkha chewing was associated
as a common habit with one of the above mentioned habit
in all of them.
The majority 35 patients (41.7%) were mucoepidermoid
carcinomas, followed by adenoid cystic carcinoma
representing (38.1%) adenocarcinoma (16.7%), and one
patient had epidermoid carcinoma (Table 3).







Do not know 41 48.8
Total 84 100






Table 3: Distribution of patients by histopathological variant
Histopathological variant
Frequency Percentage
Mucoepidermoid carcinoma 35 41.7
Adenoid cystic carcinoma 32 38.1
Adenocarcinoma 14 16.7
Epidermoid carcinoma 1 1.2
Do not know 2 2.4
Total 84 100
 Table 4: Survival analysis
Variable 2 years 5 years p-value
Disease free survival 73.3 59.7 —
Sex
Male 66.2 50.7 0.12
Female 87.2 69.7 —
Habits
No 70.8 53.9 0.55
Current 64.8 0.0 —
Do not know 72.6 66.0 —
Histopathological variant
Mucoepidermoid carcinoma 83.2 70.7 0.02*
Adenoid cystic carcinoma 81.7 55.9 —
Adenocarcinoma 51.5 0.0 —
Epidermoid carcinoma 0.0 0.0 —
*Significant
Survival Analysis
The mean follow-up was 100 months and ranged from 1 to
350 months (median 86 months) while mean disease free
time was 83.4 months (90.9 months) ranging from 1 to 350
months (median 45.5 months).
Disease free survival calculated using Kaplan-Meier
method. The time of analysis was from the date of pathologic
diagnosis to the date follow-up or death.
The overall disease free survival observed at 2 and 5
years in the present study was 73.3 and 59.7% respectively.
As shown in Table 4, the disease free survival at the end of
2 years was 66.2% for males and 87.2% for females. At the
end of 5 years the disease free survival for males decreased
to 50.7% and for females 69.7%. Statistically this difference
was not significant (0.12).
Patients with no habits had a survival of 70.8 and 53.9%
at the end of 2 and 5 years respectively. Those with current
habits had 64.8% survival at 2 years, however, all the
patients died by the end of 5 years. Patients whose habits
were not known had a survival of 72.6 and 66% at the end
of 2 and 5 years respectively. This difference too was not
significant.
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Survival was highest in patients with mucoepidermoid
carcinoma followed by adenoid cystic carcinoma (83.2 and
70.7 vs 81.7 and 55.9 at 2 and 5 years respectively) (Table 4).
Adenocarcinoma had a survival of 51.5% at the end of
2 years that fell to zero at 5 years. The difference was
statistically significant (0.02).
DISCUSSION
The management of patients with neoplasms of the salivary
glands involves multidisciplinary approach. Oral and
maxillofacial surgery and oral pathology are distinct yet
synergistic disciplines. Due to this, the number of patients
studied over a period of time are relatively small and it is
difficult to ascertain the prognostic factors with accuracy.
This study, though spans over a period of 24 years, includes
only 84 patients which is significantly less when compared
to other pathologic disease states.
In terms of salivary gland malignancy, it is a generally
accepted norm that the smaller the gland in which the tumor
arises, the greater the likelihood of its being malignant.2
The minor salivary gland tumors deviate from the other
malignant tumors being classically slow growing, with
patients being aware of its presence late. They are innocuous,
asymptomatic, and do not interfere with function.
Ulceration, a classical diagnostic sign only seen secondarily
from either masticatory or denture trauma.4
Age and Gender
Pogrel MA stated that most salivary gland tumors are slightly
more common in females and more frequently encountered
in the third to fifth decades of life.8 Anderson JA et al
reviewed 95 patients of minor salivary gland cancer and
found mean age of patients with this malignancy as 55
years.9 In the present study, no gender predisposition was
found, while the mean age at 46.7 years was a decade
younger than other series.
No statistically significant difference in relation to sex
is found in this study.
Habits
Patients from lower socioeconomic strata are largely
ignorant about the significance of early diagnosis. Their
financial problems make them adopt habits, such as
smoking, alcohol which is a predisposing factor toward
oral cancer. Poor oral hygiene significantly adds to the
problem. Most of the patients in this study were from lower
socioeconomic strata. In the present study, only a small
number of patients had habits thus, suggesting that salivary
tumors are perhaps independent of habits.
Histopathological Variants
The two most common histopathological variants in minor
salivary glands are: Mucoepidermoid carcinoma and
adenoid cystic carcinoma. Mucoepidermoid carcinoma is
the most common variant followed by adenoid cystic carcinoma
in this study. Auclair PL et al found mucoepidermoid
carcinoma to be the most common malignant lesion of major
and minor salivary glands.10 As each histopathological
variant has its own pattern of growth, spread and invasion,
and hence independent histological behavior, this highly
influences the prognosis. Adenoid cystic carcinoma accounts
for 21 to 42% of minor salivary gland carcinoma and occurs
most commonly on the hard palate. This carcinoma is
characterized by its infiltrative growth and perineural invasion.
Spread to regional lymphatics is relatively uncommon, but
hematogenous spread occurs in 25 to 50% of cases which
directly affects the prognosis. Systemic involvement is said
to occur in the presence of uncontrolled disease at the
primary site.9 The three major subtypes of adenoid cystic
carcinoma are cribriform, tubular, basaloid or solid variant.11
Adenocarcinomas are characterized by small clusters of
neoplastic cells surrounding nerve fibers in a concentric
laminated fashion, forming multifocal perineural whorls.12
They may also be arranged in solid nests, strands or
trabaculae, and in acini or tubular structures. This tumor is
rarely encountered in minor salivary glands and in this study
only 14 cases were seen over a period of 24 years.
According to Huang MX et al the histological type of
tumor is an important factor influencing prognosis.13 In
contradiction to this, Parsons JT et al stated that the
histological type did not influence survival in their review
of 95 patients with minor salivary gland cancer.14 Hyam
DM et al reviewed 30 cases of malignant minor salivary
gland tumors and concluded adenoid cystic carcinoma as
the most common histological variant.7 Jansisyanont P et al
in their retrospective study over a period of 10 years included
80 cases of minor salivary gland tumors and reported
mucoepidermoid carcinoma as the most common malignant
tumor.15 In the present study, mucoepidermoid carcinoma
had a significantly better survival at the end of 5 years
compared to adenoid cystic carcinoma and adenocarcinoma.
Similar to literature, this study too showed an influence of
histopathalogical variant on survival.
CONCLUSION
a. Mean age of the patients was 46.7 years.
b. Only a small number of patients had habits suggesting





c. Mucoepidermoid carcinoma was the most common
histopathological variant followed by adenoid cystic
carcinoma. Adenocarcinoma was the third common
histological type and only one case of epidermoid
carcinoma was found.
d. The histological type of minor salivary gland tumor was
found to significantly influence survival.
e. Gender and habits had no significant influence on
survival.
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